AGT and cardiac hypertrophy: Numerous transgenic and gene knockout animal studies, alongside clinical case reports, have demonstrated that heightened activity of the renin‐angiotensin‐aldosterone system (RAAS), particularly involving angiotensin II (Ang II) and its receptors, significantly contributes to the pathogenesis of cardiac hypertrophy.5